According to Next Move Strategy Consulting, the global Orthokeratology Lens Market is set to expand significantly, with projections estimating its size to reach USD 973 million by 2030 at a compound annual growth rate (CAGR) of 7% till 2030. Orthokeratology, often referred to as Ortho-K or Corneal Refractive Therapy (CRT), offers a non-surgical solution for refractive errors by reshaping the cornea using specially designed rigid lenses.
Unlock a FREE Sample – Try Before You Buy!
Market Growth Catalysts
Orthokeratology lenses are predominantly utilized in myopia management, a segment witnessing rapid growth due to the increasing prevalence of refractive errors globally. The surge in awareness surrounding advanced ortho-K lenses, including Vision Shaping Treatment and Corneal Refractive Therapy, coupled with FDA approvals and innovations like overnight ortho-K lenses, are driving the market’s upward trajectory.
Key Trends and Challenges
Trends Driving Growth:
- Increased Screen Time Impact: Prolonged usage of smartphones and laptops among children and young adults has exacerbated issues like myopia, asthenopia, astigmatism, and blurred vision. Orthokeratology lenses offer an effective, non-invasive solution to these growing concerns.
- Campaigns for Awareness: Initiatives like CooperVision’s 2021 campaign emphasize the importance of eye health and provide tools for practitioners to guide parents in myopia management for children.
Challenges Limiting Growth:
- High Costs and Alternatives: The preference for alternative treatments such as medications and surgical options, along with the high cost of ophthalmic equipment, pose challenges to market growth.
- Limited Adoption: Despite its benefits, orthokeratology remains a niche market within the broader contact lens segment, requiring sustained efforts to boost adoption rates.
Segmentation and Analysis
The orthokeratology lens market is segmented by product type, material, application, end-user, and geography:
By Product:
- Daytime Ortho-K Lenses
- Overnight Ortho-K Lenses (dominating segment due to convenience and efficacy)
By Material:
- Silicone Acrylate
- Fluorosilicone Acrylate
- Fluorocarbon Acrylate
By Application:
- Myopia
- Hyperopia
- Presbyopia
- Astigmatism
By End-User:
- Hospitals
- Vision Care Centers
- Ophthalmic Clinics
- Others
Geographical Insights
North America:
North America holds the largest revenue share, driven by advancements in orthokeratology products and strategies by market leaders. Collaborations such as the partnership between Johnson & Johnson Vision and Menicon in April 2021 exemplify efforts to combat myopia in children.
Asia-Pacific:
Asia-Pacific is poised for exponential growth, attributed to the adoption of advanced products, a growing geriatric population, and increased awareness of eye health. For example, Menicon’s establishment of a subsidiary in China in December 2020 reflects the region’s growth potential.
Competitive Landscape
The market is moderately fragmented, with key players including CooperVision, Euclid Systems Corporation, Art Optical Contact Lens, Inc., Wave LLC, and others. Companies are leveraging product launches and regional expansions to maintain their market presence:
Market Opportunities
Growing awareness campaigns, technological advancements, and the rising prevalence of myopia present lucrative opportunities for players in the orthokeratology lens market. The focus on innovative solutions and expanding accessibility is expected to bridge gaps in adoption, making Ortho-K lenses a critical component in global eye care.
Conclusion
With the rising burden of refractive errors and the demand for non-surgical solutions, the orthokeratology lens market is primed for robust growth. By addressing challenges such as high costs and increasing awareness through targeted campaigns, industry leaders can unlock the market’s full potential. As technological advancements continue to reshape the eye care landscape, orthokeratology lenses are set to play an integral role in enhancing vision health worldwide.
